Hisamitsu Pharma Indonesia is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Jawa Timur. The company was founded in 1975. Hisamitsu Pharma Indonesia is a subsidiary of Hisamitsu Pharmaceutical Co., Inc., a renowned Japanese pharmaceutical company known for its development and production of topical pain relief products. The parent company was founded by Naojiro Hisamitsu in 1847 and is headquartered in Saga, Japan. Hisamitsu Pharma Indonesia focuses on the production and distribution of pharmaceutical products, with a primary emphasis on transdermal therapeutic systems. The company is well-known for its flagship product, Salonpas, a popular pain relief patch that has gained significant market presence both locally and internationally. In Indonesia, Hisamitsu Pharma operates several branches and distribution centers to ensure the widespread availability of its products across the archipelago. The company also exports its products to various countries, contributing to its global footprint. Hisamitsu Pharma Indonesia collaborates with healthcare professionals and institutions to promote health and wellness through innovative pharmaceutical solutions. The company is a member of several pharmaceutical and healthcare associations, which helps it stay at the forefront of industry developments. With a commitment to improving quality of life through effective pain management solutions, Hisamitsu Pharma Indonesia continues to invest in research and development to expand its product offerings and enhance its technological capabilities. The company's mission is to deliver innovative healthcare products that meet the needs of consumers and healthcare providers worldwide.
Headquarters
Kab. Sidoarjo Banjarkemantren Buduran Jawa Timur
Sidoarjo; East Java;
Postal Code: 61252
Contact Details: Purchase the PT Hisamitsu Pharma Indonesia report to view the information.
Website: http://www.hisamitsu.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service